Cao, Bing

Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis

Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 1,554

Stress, epigenetics and depression: A systematic review

Park, C., Rosenblat, J. D., Brietzke, E., Pan, Z., Lee, Y., Cao, B., Zuckerman, H., Kalantarova, A., & McIntyre, R. S. (2019) · Neuroscience & Biobehavioral Reviews

Epigenetics and DNA MethylationStress Responses and Cortisol

Cited by 465

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis

Alnefeesi, Y., Chen-Li, D., Krane, E., Jawad, M. Y., Rodrigues, N. B., Ceban, F., Di Vincenzo, J. D., Meshkat, S., Ho, R. C. M., Gill, H., et al. (2022) · Journal of Psychiatric Research

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 186

Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review

Cao, B., Zhu, J., Zuckerman, H., Rosenblat, J. D., Brietzke, E., Pan, Z., Subramanieapillai, M., Park, C., Lee, Y., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 175

The efficacy of vortioxetine on anhedonia in patients with major depressive disorder

Cao, B., Park, C., Subramaniapillai, M., Lee, Y., Iacobucci, M., Mansur, R. B., Zuckerman, H., Phan, L., & McIntyre, R. S. (2019) · Frontiers in Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 139

Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review

Cooper, D. H., Ramachandra, R., Ceban, F., Di Vincenzo, J. D., Rhee, T. G., Mansur, R. B., Teopiz, K. M., Gill, H., Ho, R., Cao, B., et al. (2023) · Journal of Psychiatric Research

Diabetes Treatment and ManagementTreatment of Major Depression

Cited by 79

Metabolic Profiling Identifies Phospholipids as Potential Serum Biomarkers for Schizophrenia

Wang, D., Cheng, S. L., Fei, Q., Gu, H., Raftery, D., Cao, B., Sun, X., Yan, J., Zhang, C., & Wang, J. (2019) · Psychiatry Research

Metabolomics and Mass Spectrometry StudiesSchizophrenia research and treatment

Cited by 73

Development and implementation of guidelines for the management of depression: a systematic review

Lee, Y., Brietzke, E., Cao, B., Chen, Y., Linnaranta, O., Mansur, R. B., Cortes, P., Kösters, M., Majeed, A., Tamura, J. K., et al. (2020) · Bulletin of the World Health Organization

Clinical practice guidelines implementationMental Health Treatment and Access

Cited by 45

Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series

Lipsitz, O., Di Vincenzo, J. D., Rodrigues, N. B., Cha, D. S., Lee, Y., Greenberg, D., Teopiz, K. M., Ho, R. C., Cao, B., Lin, K., et al. (2021) · The American Journal of Geriatric Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 40

Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials

Akbar, D., Rhee, T. G., Ceban, F., Ho, R., Teopiz, K. M., Cao, B., Subramaniapillai, M., Kwan, A. T. H., Rosenblat, J. D., & McIntyre, R. S. (2023) · CNS Drugs

Treatment of Major DepressionPsychological Treatments and Disorders

Cited by 38

Interventions targeting comorbid depression and overweight/obesity: A systematic review

Cao, B., Xu, J., Li, R., Teopiz, K. M., McIntyre, R. S., & Chen, H. (2022) · Journal of Affective Disorders

Eating Disorders and BehaviorsObesity, Physical Activity, Diet

Cited by 32

Biomarkers of ketamine’s antidepressant effect: An umbrella review

Meshkat, S., Ho, R. C., Cao, B., Teopiz, K. M., Rosenblat, J. D., Rhee, T. G., Di Vincenzo, J. D., Ceban, F., Jawad, M. Y., & McIntyre, R. S. (2023) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 29

Characterising Phospholipids and Free Fatty Acids in Patients with Schizophrenia: A Case-Control Study

Wang, D., Sun, X., Maziade, M., Mao, W., Zhang, C., Wang, J., & Cao, B. (2021) · The World Journal of Biological Psychiatry

Schizophrenia research and treatmentMetabolomics and Mass Spectrometry Studies

Cited by 26

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

Rashidian, H., Subramaniapillai, M., Park, C., Lipsitz, O., Zuckerman, H., Cao, B., Lee, Y., Gill, H., Rodrigues, R. N., Di Vincenzo, J. D., et al. (2023) · Journal of Psychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 23

Mindfulness Training Improves Attention: Evidence from Behavioral and Event-related Potential Analyses

Liu, Y., Hou, Y., Quan, H., Zhao, D., Zhao, J., Cao, B., Pang, Y., Chen, H., Lei, X., & Yuan, H. (2023) · Brain Topography

Mindfulness and Compassion InterventionsMind wandering and attention

Cited by 22

A systematic review of anti-suicidal effects of sedative-hypnotics and cognitive behavioral therapy for insomnia

Valentino, K., Teopiz, K., Wong, S., Le, G. H., Badulescu, S., Johnson, D., Ho, R., Rhee, T. G., Cao, B., Rosenblat, J., et al. (2025) · CNS Spectrums

Sleep and related disordersSuicide and Self-Harm Studies

Cited by 12